Tehran University of Medical Sciences

Science Communicator Platform

Share By
Expanding the Genetic and Clinical Landscapes of Hereditary Spastic Paraplegia (Hsp): A Cohort Study of 103 Families Publisher Pubmed



Davarzani A ; Ravanbod M ; Ghasemi A ; Mohammadi M ; Rohani M ; Nafissi S ; Jamali P ; Najmabadi H ; Fatehi F ; Alavi S ; Firoozfar Z ; Zemorshidi F ; Habibi Kavashkohie M R ; Alavi A
Authors

Source: Orphanet Journal of Rare Diseases Published:2026


Abstract

Background: Hereditary spastic paraplegia (HSP) refers to a heterogeneous group of genetic disorders with more than 90 causative genes. Clinically, HSP is classified into pure and complicated forms. Pure forms are characterized primarily by lower-limb spasticity and weakness, whereas complicated forms include additional neurological or non-neurological symptoms alongside spasticity and weakness. We aimed to characterize the clinical and genetic landscapes of HSP in an Iranian cohort. Whole-exome sequencing (WES) was performed on 103 unrelated clinically suspected HSP probands. Multiple ligation-dependent probe amplification (MLPA) was performed to validate identified copy number variants (CNVs) in two probands. Results: 71 pathogenic/likely pathogenic and VUS variants were identified in 81 probands; total genetically solved probands: 78.6%. Among these solved cases, 64 probands harbored variants in known HSP genes, 14 had variants in other neuromuscular/neurodegenerative-related genes, and the remaining 3 probands carried variants in four novel candidate genes including NMNAT1, SEMA3A, KCNJ14, and EMP3. Among all 71 identified genomic variants, two were CNVs and one was a trinucleotide repeat expansion. Taken together, these variants were located in 37 genes; 21 of these genes have been previously implicated in HSP, and four common HSP subtypes (SPG11, SPG4, SPG7, and SPG15) accounted for ~40% of our cohort. Conclusions: This study demonstrates significant clinical and genetic heterogeneity of HSP within our cohort. In addition to variants in 21 known HSP-related genes, we identified variants in 14 genes related to other neurological disorders -highlighting shared biological pathways- as well as variants in four novel candidate genes. Notably, a genetic diagnosis could not be established in 22 probands, underscoring that additional, as yet unidentified genes likely contribute to HSP pathogenesis. © The Author(s) 2026.
Related Docs
View other Related Docs
1. Copy Number Variations in Hereditary Spastic Paraplegia-Related Genes: Evaluation of an Iranian Hereditary Spastic Paraplegia Cohort and Literature Review, Molecular Syndromology (2023)
2. Three Iranian Patients With Rare Subtypes of Hereditary Spastic Paraplegia (Hsp): Spg76, Spg56, and Spg69, Neurogenetics (2025)
3. Description of Combined Arhsp/Jals Phenotype in Some Patients With Spg11 Mutations, Molecular Genetics and Genomic Medicine (2020)
Experts (# of related papers)
View all Related Experts
Shahriar Nafissi (2)
Mohammad Kazem Bakhshandeh-Bali (2)
Other Related Docs
4. Description of Clinical Features and Genetic Analysis of One Ultra-Rare (Spg64) and Two Common Forms (Spg5a and Spg15) of Hereditary Spastic Paraplegia Families, Journal of Neurogenetics (2021)
5. A Case Report of Concurrent Occurrence of Two Inherited Axonopathies Within a Family: The Benefit of Whole-Exome Sequencing, International Journal of Neuroscience (2023)
6. Bi-Allelic Variants in Rnf170 Are Associated With Hereditary Spastic Paraplegia, Nature Communications (2019)
7. Jam2 Variants Can Be More Common in Primary Familial Brain Calcification (Pfbc) Cases Than Those Appear; May Be Due to a Founder Mutation, Neurological Sciences (2024)
8. Identifying Novel Agrn Variants in Congenital Myasthenic Syndrome: Insights From Three Iranian Families, Neuromuscular Disorders (2025)
9. A Homozygous Tars2 Variant Is a Novel Cause of Syndromic Neonatal Diabetes, Diabetic Medicine (2025)
10. Clinical Spectrum in Multiple Families With Primary Coq10 Deficiency, American Journal of Medical Genetics# Part A (2021)
11. Genetic Variant Profiling of Neonatal Diabetes Mellitus in Iranian Patients: Unveiling 58 Distinct Variants in 14 Genes, Journal of Diabetes Investigation (2024)
12. Mutational Spectrum and Clinical Symptoms of Iranian Patients With Charcot-Marie-Tooth Disease: A Study of 23 Patients, Journal of Iranian Medical Council (2023)
13. Novel Variants and Rare Clinical Presentations in Mfn2-Related Charcot-Marie-Tooth Disease: Insights From 10 Families, Revue Neurologique (2026)
14. The Second Family Affected With a Prdm8-Related Disease, Neurological Sciences (2022)
15. A Founder Mutation in Coq7, P.(Leu111pro), Causes Pure Hereditary Spastic Paraplegia (Hsp) in the Iranian Population, Neurological Sciences (2023)
16. Clinical and Molecular Findings of Autosomal Recessive Spastic Ataxia of Charlevoix Saguenay: An Iranian Case Series Expanding the Genetic and Neuroimaging Spectra, Cerebellum (2023)
17. Identification of Uba1 As the Causative Gene of an X-Linked Non-Kennedy Spinal–Bulbar Muscular Atrophy, European Journal of Neurology (2022)
18. Clinical and Molecular Assessment of a Spastic Ataxia 4 (Spax4) Patient With a Novel Variant in the Mtpap Gene, and a Systematic Review, Gene (2025)
19. Whole Genome Sequencing Identifies a Novel Homozygous Exon Deletion in the Nt5c2 Gene in a Family With Intellectual Disability and Spastic Paraplegia, npj Genomic Medicine (2017)